作者: Silvia Paoletta , Stephanie Federico , Giampiero Spalluto , Stefano Moro
DOI: 10.1016/B978-0-12-381296-4.00013-0
关键词:
摘要: Abstract The field of therapeutic application the A 3 adenosine receptor (A AR) antagonists represents a rapidly growing and intense area research in field. Even if there are currently no AR clinical phases, light plethora biological effects attributed to ARs, substantial efforts medicinal chemistry have been directed toward developing for subtype. In this review, we summarize more recent promising evidences possible as drug candidates, role receptor-driven design their silico characterization.